Does Inflammation Raise Blood Sugar?

Inflammation does raise blood sugar, and it does so through multiple overlapping mechanisms that affect how your cells respond to insulin, how much insulin your pancreas can produce, and how efficiently your body clears glucose from the bloodstream. The connection runs deep enough that some researchers now consider chronic, low-grade inflammation a core driver of type 2 diabetes rather than just a side effect. The relationship also runs in both directions: high blood sugar itself triggers more inflammation, creating a self-reinforcing cycle that helps explain why metabolic problems tend to snowball over time.

How Inflammation Jams the Insulin Signal

To understand why inflammation pushes blood sugar up, you need to know what normally happens when insulin arrives at a cell. Insulin binds to a receptor on the cell surface, which kicks off a chain of internal signals telling the cell to open its doors to glucose. Inflammatory molecules interrupt that chain. Specifically, immune signals like tumor necrosis factor alpha (TNF-alpha) activate internal stress pathways that physically alter a key docking protein inside the cell, changing it in a way that weakens the insulin signal before it can do its job.

Research in both human subjects and lab models has shown that TNF-alpha infusion directly reduces insulin signaling in skeletal muscle, the tissue responsible for clearing the majority of glucose from your blood after a meal. The inflammatory signal triggers stress-related enzymes that scramble the normal relay, so insulin still arrives at the cell but fails to deliver its full message.¹ The same pathways have been confirmed in studies of muscle cells, where TNF-alpha causes a specific modification on the insulin relay protein IRS-1 that blocks its normal function.² Two enzymes consistently implicated in this process, JNK1 and IKKβ, are now considered central links between excess body fat, inflammation, and insulin resistance.³

What makes this especially relevant is that these same stress pathways turn on a master inflammatory switch called NF-κB. Once active, NF-κB drives the production of even more inflammatory molecules, which recruit more immune cells, which produce more TNF-alpha and other signals, and the cycle deepens. Experiments in animal models have shown that genetically reducing the activity of this pathway, or blocking it with anti-inflammatory drugs like salicylates, improved insulin sensitivity.⁴

What Happens During Acute Illness

If you have ever checked your blood sugar while sick with an infection or after surgery, you may have noticed it was higher than usual. This is not random. During severe illness like sepsis, blood sugar spikes are so common that they are recognized as an independent risk factor for poor outcomes. Multiple mechanisms drive this: the body floods the bloodstream with stress hormones that promote glucose production in the liver, inflammatory molecules trigger insulin resistance across tissues, and enzyme systems that normally help regulate blood sugar get disrupted.⁵

This stress-driven hyperglycemia is actually the body’s emergency response: pushing extra fuel into the bloodstream for immune cells and vital organs that need energy to fight the threat. The problem arises when the inflammation does not resolve quickly. An evolutionary medicine perspective suggests that this response was shaped for acute crises like infections, which the body expects to resolve within a few weeks. When inflammation becomes chronic, that same fuel-diverting system stays switched on long after the emergency has passed, keeping blood sugar chronically elevated.⁶

Chronic Low-Grade Inflammation and the Creep Toward Diabetes

The type of inflammation most relevant to rising blood sugar in everyday life is not the dramatic kind you get with a wound or an infection. It is a subtler, persistent hum of immune activation that often accompanies excess body fat. In people with obesity, fat tissue becomes infiltrated by immune cells called macrophages. These macrophages shift from an anti-inflammatory state to a pro-inflammatory one, steadily pumping out cytokines that impair insulin signaling in muscle, fat, and liver.⁷

One of the most widely measured markers of this low-grade inflammation is C-reactive protein (CRP), a protein produced by the liver in response to inflammatory signals. In a large Korean population study, people in the highest third of CRP levels had roughly two to three times the risk of developing type 2 diabetes compared with those in the lowest third, with the association being stronger in women.⁸ CRP does not cause diabetes on its own, but it serves as a reliable thermometer for the kind of systemic inflammation that does.

The Feedback Loop Nobody Wants

One of the most frustrating aspects of this relationship is that it runs in both directions. Inflammation raises blood sugar, and high blood sugar then fuels more inflammation. Research on vascular cells has shown that when glucose floods into cells pushed there by inflammatory signals like IL-1β, the excess glucose gets routed through an alternative metabolic pathway that generates reactive oxygen species. Those free radicals then trigger even more downstream pro-inflammatory signaling.⁹

This two-way street is a big part of why metabolic decline tends to accelerate. A little inflammation leads to a little insulin resistance, which leads to slightly higher blood sugar, which produces more oxidative stress, which amplifies the inflammation. Without intervention, each round nudges the system further out of balance. It also helps explain why complications of diabetes, including damage to blood vessels, nerves, and kidneys, are themselves strongly associated with inflammatory markers.

How Your Gut Contributes

A less obvious source of the inflammation that drives blood sugar up comes from the gut. Your intestinal lining normally acts as a selective barrier, letting nutrients through while keeping bacterial products out. But dietary changes, particularly a high-fat, low-fiber Western-style diet, can damage that barrier. When it weakens, fragments of bacterial cell walls called lipopolysaccharide (LPS) leak into the bloodstream. This is sometimes called metabolic endotoxemia, and it triggers an immune response that produces the same kinds of pro-inflammatory cytokines implicated in insulin resistance.¹⁰

A study of obese and diabetic women in Gambia found a positive association between endotoxin levels in the blood and fasting glucose. The data also showed that lower levels of protective anti-endotoxin antibodies were linked to both higher fasting glucose and higher fasting insulin, suggesting that the body’s ability to neutralize gut-derived inflammatory triggers matters for blood sugar control.¹¹ This gut-inflammation-glucose connection has prompted interest in dietary and probiotic interventions that might restore barrier integrity and reduce systemic inflammation from this source.

When Inflammation Kills the Insulin Factory

Inflammation does not only make your cells deaf to insulin; it can also damage the cells that produce it. The beta cells in your pancreas, the ones responsible for making and releasing insulin, are particularly vulnerable to inflammatory stress. Inflammatory cytokines like TNF-alpha and IL-1β are consistently associated with beta-cell failure in both lab models and people with type 2 diabetes.¹²

The damage involves the same NF-κB pathway discussed earlier. When inflammatory signals activate pattern-recognition receptors on beta cells, the result is a cascade that promotes the release of more cytokines and ultimately triggers programmed cell death in the beta cells themselves.¹³ Stress-driven inflammation can further alter the structure of pancreatic islets by inducing this apoptosis.¹⁴ So over time, chronic inflammation does double damage: it makes existing insulin less effective and reduces how much insulin your body can make. That combination is essentially the recipe for type 2 diabetes.

Rheumatoid Arthritis as a Real-World Example

One of the clearest demonstrations that inflammation raises blood sugar comes from looking at people with chronic inflammatory diseases. Rheumatoid arthritis (RA) provides a compelling case study. RA patients have a considerably higher incidence of abnormal glucose metabolism compared with the general population, and the persistent systemic inflammatory state of the disease is thought to be a major driver.¹⁵ The severity of the disease matters too: people with more active RA tend to have worse insulin resistance, and the relationship tracks with inflammatory cytokine levels like TNF-alpha and IL-6.¹⁶

A revealing comparison between RA patients and people with osteoarthritis (a much less inflammatory joint condition) found that RA patients had higher CRP, lower insulin sensitivity, and more cases of diabetes. When researchers statistically controlled for CRP levels, the difference in insulin sensitivity between the two groups largely disappeared, strongly suggesting that the inflammation itself, rather than some other feature of having joint disease, was responsible for the metabolic difference.¹⁷

The Glucocorticoid Catch-22

There is an irony built into treating inflammatory diseases. Glucocorticoids like prednisone are among the most widely used anti-inflammatory drugs, but they themselves raise blood sugar. They do this by increasing glucose production in the liver, reducing insulin sensitivity in tissues, and impairing beta-cell function.¹⁸ For someone with RA or another chronic inflammatory condition, this creates a genuine dilemma: the inflammation drives blood sugar up, but so does the most common class of drugs used to fight it. This is one reason rheumatologists increasingly favor disease-modifying agents that target specific inflammatory pathways without the broad metabolic side effects of steroids.

More targeted anti-inflammatory approaches have shown some promise for metabolic outcomes. Clinical data support the concept that targeting inflammation can improve insulin sensitivity and beta-cell function. However, the improvements in glucose control seen in most trials of anti-inflammatory therapies, whether in patients with autoimmune conditions or those with type 2 diabetes, have been modest rather than dramatic.¹⁹ Inflammation is clearly part of the metabolic problem, but it is not the entire problem; fixing it alone does not fully normalize blood sugar.

The Exercise Paradox

If inflammation raises blood sugar, you might expect that exercise, which causes a temporary spike in inflammatory markers, would also worsen glucose control. The opposite is true, and IL-6 is the molecule that makes this paradox interesting. IL-6 is elevated in people with chronic inflammatory diseases, where it contributes to insulin resistance. But it is also released in large amounts by working muscles during exercise, and in that context, it is associated with improved insulin sensitivity.²⁰

Studies of exercising human muscle have found a strong positive relationship between IL-6 release from the working leg and glucose uptake by that same tissue. The more IL-6 the muscle released, the more glucose it pulled from the blood.²¹ The difference comes down to context. Chronic, low-grade IL-6 from inflamed fat tissue activates one set of downstream signals that promote insulin resistance. Acute, pulsatile IL-6 from exercise activates a different set that enhances glucose uptake. The molecule is the same, but the pattern and source of its release determine whether the outcome is metabolically harmful or helpful.

Sleep, Diet, and the Inflammation You Can Influence

Beyond disease states, everyday lifestyle factors can tip the inflammation-glucose balance in either direction. Sleep deprivation is a potent promoter of both inflammation and impaired glucose metabolism. Experimental studies have shown that restricting sleep raises cortisol levels, increases pro-inflammatory markers, and disrupts normal glucose handling.²² For people already dealing with insulin resistance, chronic short sleep adds fuel to the fire.

On the dietary side, what you eat after meals has measurable effects on both glucose and inflammatory markers. Diets heavy in processed food and low in fiber tend to produce large post-meal glucose spikes, which themselves provoke inflammatory responses. A diet centered on minimally processed foods, whole grains, legumes, vegetables, fruits, and nuts blunts those spikes and reduces post-meal inflammation. Eating patterns like the traditional Mediterranean diet have been shown to reduce both inflammatory markers and cardiovascular risk in experimental and observational studies.²³ Given the feedback loop between glucose and inflammation, dampening either side of the cycle has the potential to slow down the other.

Can Inflammation Reprogram Your Internal Clock

Your pancreatic beta cells do not produce insulin at a constant rate throughout the day. They follow a circadian rhythm, ramping up production in anticipation of meals and pulling back during sleep. Research has shown that inflammatory cytokines can disrupt this internal clock. Exposure to IL-1β dampened the amplitude of circadian gene oscillations in beta cells by roughly 80% and suppressed a key clock gene called Bmal1 in a dose-dependent manner.²⁴ When the clock is disrupted, the fine-tuned timing of insulin release breaks down, contributing to the glucose mismanagement seen in diabetes.

This finding adds another layer to the inflammation-glucose story. It is not just that inflammation makes cells resistant to insulin or kills off beta cells; it also throws off the timing of the insulin response itself. Since circadian disruption from shift work, irregular eating schedules, and poor sleep is already known to worsen metabolic health, the possibility that inflammation compounds this by attacking the clock mechanism directly suggests these risk factors may amplify each other rather than just adding up.

Maternal Inflammation and Metabolic Risk in Offspring

The reach of inflammation-driven metabolic disruption may extend across generations. Research into developmental programming has shown that the environment a fetus develops in can shape its metabolic trajectory for life. Maternal obesity is associated with a chronic low-grade inflammatory state during pregnancy, and that inflammatory milieu can alter how tissues develop in the fetus, predisposing the offspring to obesity, insulin resistance, and cardiovascular problems in adulthood.²⁵ The mechanisms are not fully mapped, but the concept that inflammation during critical windows of development can set a metabolic thermostat that persists into the next generation is gaining traction. From an evolutionary standpoint, this programming may have been adaptive: if the mother’s environment was calorie-scarce and infection-heavy, preparing the offspring for that same harsh environment made sense. In the modern world of caloric abundance, those same programs become a liability.²⁶